Moderna shares up 2% as skin cancer vaccine shows sustained benefit in five-year follow-up 0 20.01.2026 19:02 Economictimes.indiatimes.com Moderna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of the most deadly skin cancer five years after the treatment started. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
